|
Leslie Platt is a Principal in Ernst & Young LLP and Leader
of the Health Sciences Research Compliance Group based in
McLean, VA, and Washington, DC. The Group provides services
to the biotechnology, pharmaceutical and health care industries.
Mr. Platt has over 25 years of professional services experience,
including many years at senior levels in the private and public
sectors. He has served as Executive Assistant to the Director
and Chief of Operations, Office of the Director, National
Institutes of Health (NIH), and has been general counsel and
a senior executive of two biotechnology organizations. Earlier
in his career, he was Deputy General Counsel-Legal Counsel
of the U.S. Department of Health and Human Services and staff
director and counsel of the White House Agent Orange Working
Group. At the outset of his career, Mr. Platt served as chief
legislative counsel of the U.S. Department of Housing and
Urban Development.
Mr. Platt has extensive experience in addressing business,
legal and policy issues facing biomedical research and health
care organizations, as well as other companies, nonprofit
entities and government agencies. He has negotiated landmark
agreements in biotechnology facility finance and intellectual
property transfer, and is the recipient of numerous awards
for outstanding service. Mr. Platt is a frequent lecturer
on bioethics and legal and policy issues in health and life
sciences, and is co-chair of the Biotechnology Industry Organization’s
BIO Judiciary Project (www.biojudiciary.org).
He has served as a member of the Task Force on Genetic Technologies
of the National Conference of State Legislatures and as a
member of the International Bar Association Working Group
on the Draft International Convention on the Human Genome.
Mr. Platt is a graduate of New York University School of Law
and a member of the Bar of the District of Columbia. Mr. Platt
is first inventor on a pending patent for regulatory compliance
monitoring and reporting. |